A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Ditching Invading DNA: Bacteria and archaea protect themselves from invasive foreign nucleic acids through an RNA-mediated adaptive immune system called CRISPR (clustered regularly interspaced short palindromic repeats)/CRISPR-associated (Cas). Jinek et al. (p. 816 , published online 28 June; see the Perspective by Brouns ) found that for the type II CRISPR/Cas system, the CRISPR RNA (crRNA) as well as the trans-activating crRNA—which is known to be involved in the pre-crRNA processing—were both required to direct the Cas9 endonuclease to cleave the invading target DNA. Furthermore, engineered RNA molecules were able to program the Cas9 endonuclease to cleave specific DNA sequences to generate double-stranded DNA breaks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Repurposing bacterial “CRISPR” systems to facilitate RNA-guided cleavage of complementary DNA has revolutionized the field of gene editing in mammalian cells 1–4.”
From A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells (2018) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“To realize this promise, the development of CRISPR-Cas9 for genome editing offers a simpler technology that has been adopted widely due to the ease of programming its DNA binding and modifying capabilities.”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recombinant expression and purification of EvoCas9–1 paired with chemically synthesized Evo-generated single guide RNA (sgRNA) exhibited comparable in vitro cleavage activity to SpCas9 paired with the canonical SpCas9 sgRNA”
From Sequence modeling and design from molecular to genome scale with Evo (2024) · cites this paper as [62]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Cas9 can create DNA cleavage at desired genomic positions that are guided by precise base pairing between sgRNA and DNA, adjacent to a protospacer-adjacent motif (PAM) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CRISPR/Cas9 is a class of ribonucleoprotein complexes formed by a Cas9 protein and a single guide RNA (sgRNA) (Jinek et al., 2012; Cho et al., 2013; Cong et al., 2013; Wang et al., 2016a).”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Jinek et al., 2012
Experimental — accuracy not yet measured
31 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Evolution and classification of the CRISPR–Cas systems
Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J. M., Wolf, Y. I., Yakunin, A. F., et al. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2577 · Cited by 2,331
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Genome editing with engineered zinc finger nucleases
Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S., & Gregory, P. D. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2842 · Cited by 2,285
A TALE nuclease architecture for efficient genome editing
Miller, J. C., Tan, S., Qiao, G., Barlow, K. A., Wang, J., Xia, D. F., Meng, X., Paschon, D. E., Leung, E., Hinkley, S. J., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1755 · Cited by 2,098
Targeting DNA Double-Strand Breaks with TAL Effector Nucleases
Christian, M., Cermak, T., Doyle, E. L., Schmidt, C., Zhang, F., Hummel, A., Bogdanove, A. J., & Voytas, D. F. (2010) · Genetics · doi:10.1534/genetics.110.120717 · Cited by 1,869
Cited by
Items 601–700 of 1,285
CRISPR-mediated live imaging of genome editing and transcription
Wang, H., Nakamura, M., Abbott, T. R., Zhao, D., Luo, K., Yu, C., Nguyen, C. M., Lo, A., Daley, T. P., La Russa, M., et al. (2019) · Science · doi:10.1126/science.aax7852 · Cited by 299
“Fluorescent protein-fused, nuclease-deac-tivated dCas9 or single guide RNA (sgRNA) recruiting fluorescent protein-fused RNA-binding proteins enable CRISPR-mediated live imaging of genomic loci ( 4 – 7 ).”
Organoid cystogenesis reveals a critical role of microenvironment in human polycystic kidney disease
Cruz, N. M., Song, X., Czerniecki, S. M., Gulieva, R. E., Churchill, A. J., Kim, Y. K., Winston, K., Tran, L. M., Diaz, M. A., Fu, H., et al. (2017) · Nature Materials · doi:10.1038/nmat4994 · Cited by 291
“1a-b) 6, 11 .”
Comparison of CRISPR/Cas9 expression constructs for efficient targeted mutagenesis in rice
Mikami, M., Toki, S., & Endo, M. (2015) · Plant Molecular Biology · doi:10.1007/s11103-015-0342-x · Cited by 296
“CAPS Cleaved amplified polymorphic sequences Cas9 CRISPR-associated endonuclease 9 CIM Callus induction medium CRISPR Clustered regularly interspaced short palindromic repeat DL Drooping leaf gRNA Guide RNA HMF Highest mutation frequency NLS Nuclear localization signal nt Nucleotide PAM Protospacer adjacent motif PDS…”
Efficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease
Qin, W., Dion, S. L., Kutny, P. M., Zhang, Y., Cheng, A. W., Jillette, N. L., Malhotra, A., Geurts, A. M., Chen, Y.-G., & Wang, H. (2015) · Genetics · doi:10.1534/genetics.115.176594 · Cited by 293
“…re-peat (CRISPR) locus and the CRISPR-associated protein (Cas) system, CRISPR/Cas9, is an acquired immune system in bacteria and archaea that has recently been exploited for genome engineering of many species and cell types (Jinek et al. 2012; Doudna and Charpentier 2014; Hsu et al. 2014).”
BackgroundA CRISPR–dCas Toolbox for Genetic Engineering and Synthetic Biology
Xu, X., & Qi, L. S. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.06.037 · Cited by 291
CRISPR Crops: Plant Genome Editing Toward Disease Resistance
Langner, T., Kamoun, S., & Belhaj, K. (2018) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080417-050158 · Cited by 281
“These include zinc-finger nucleases (ZFNs) (145), TAL (transcription-activator-like) effector nucleases (TALENs) (28, 30, 49, 156), and CRISPR (clustered regularly interspaced palindromic repeat) RNA–guided Cas (CRISPR-associated protein) endonucleases, which can be programmed with different degrees of ease to target…”
BackgroundMethodInfluentialRasala, B. A., & Mayfield, S. P. (2015) · Photosynthesis Research · doi:10.1007/s11120-014-9994-7 · Cited by 290
Kearns, N. A., Genga, R. M. J., Enuameh, M. S., Garber, M., Wolfe, S. A., & Maehr, R. (2014) · Development · doi:10.1242/dev.103341 · Cited by 294
“A separate U6 promoter-based lentiviral delivery system for sgRNA expression was generated to program dCas9-E for specific genomic targets (Jinek et al., 2012).”
BackgroundMethodInfluentialRefined sgRNA efficacy prediction improves large- and small-scale CRISPR–Cas9 applications
Labuhn, M., Adams, F. F., Ng, M., Knoess, S., Schambach, A., Charpentier, E. M., Schwarzer, A., Mateo, J. L., Klusmann, J.-H., & Heckl, D. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1268 · Cited by 293
“Due to the controversy regarding a functional seed region for logical splitting (1,40,45,46), we split the sgRNA sequence into 50% intervals starting with a PAM-proximal and a PAM-distal half and analyzed their GC-content independently (Figure 3DE).”
MethodSelf-citationHorwitz, A. A., Walter, J. M., Schubert, M. G., Kung, S. H., Hawkins, K., Platt, D. M., Hernday, A. D., Mahatdejkul-Meadows, T., Szeto, W., Chandran, S. S., et al. (2015) · Cell Systems · doi:10.1016/j.cels.2015.02.001 · Cited by 297
“We adopted the standard ‘‘chimeric’’ configuration, in which the targeting and structural RNAs are fused to create a single gRNA (Jinek et al., 2012; Cho et al., 2013; Ran et al., 2013).”
MethodZhou, T., Huang, R., Huang, M., Shen, J., Shan, Y., & Xing, D. (2020) · Advanced Science · doi:10.1002/advs.201903661 · Cited by 292
Programmable RNA editing by recruiting endogenous ADAR using engineered RNAs
Qu, L., Yi, Z., Zhu, S., Wang, C., Cao, Z., Zhou, Z., Yuan, P., Yu, Y., Tian, F., Liu, Z., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0178-z · Cited by 277
CRISPR-Cas and restriction–modification systems are compatible and increase phage resistance
Dupuis, M.-È., Villion, M., Magadán, A. H., & Moineau, S. (2013) · Nature Communications · doi:10.1038/ncomms3087 · Cited by 288
Zhu, J., Avakyan, N., Kakkis, A., Hoffnagle, A. M., Han, K., Li, Y., Zhang, Z., Choi, T. S., Na, Y., Yu, C.-J., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00308 · Cited by 285
Tatineni, S., & Hein, G. L. (2023) · Phytopathology® · doi:10.1094/phyto-05-22-0167-rvw · Cited by 263
The delivery challenge: fulfilling the promise of therapeutic genome editing
van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N., & Schaffer, D. V. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0565-5 · Cited by 285
A Co-CRISPR Strategy for Efficient Genome Editing in Caenorhabditis elegans
Kim, H., Ishidate, T., Ghanta, K. S., Seth, M., Conte, D., Shirayama, M., & Mello, C. C. (2014) · Genetics · doi:10.1534/genetics.114.166389 · Cited by 294
“Primer sequences are listed in Table S3.”
BackgroundCRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections
van Diemen, F. R., Kruse, E. M., Hooykaas, M. J. G., Bruggeling, C. E., Schürch, A. C., van Ham, P. M., Imhof, S. M., Nijhuis, M., Wiertz, E. J. H. J., & Lebbink, R. J. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005701 · Cited by 290
“Additionally, we replaced the mouse U6 promoter with a human U6 promoter which drives expression of a guideRNA (gRNA) consisting of a 18-20bp target-specific CRISPR RNA (crRNA) fused to the trans -acti- vating crRNA (tracrRNA) [88] and a terminator sequence.”
Huang, M., Zhou, X., Wang, H., & Xing, D. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b04542 · Cited by 284
González, M. N., Massa, G. A., Andersson, M., Turesson, H., Olsson, N., Fält, A.-S., Storani, L., Décima Oneto, C. A., Hofvander, P., & Feingold, S. E. (2020) · Frontiers in Plant Science · doi:10.3389/fpls.2019.01649 · Cited by 285
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
Goldberg, G. W., Jiang, W., Bikard, D., & Marraffini, L. A. (2014) · Nature · doi:10.1038/nature13637 · Cited by 293
Remarkable Mechanisms in Microbes to Resist Phage Infections
Dy, R. L., Richter, C., Salmond, G. P. C., & Fineran, P. C. (2014) · Annual Review of Virology · doi:10.1146/annurev-virology-031413-085500 · Cited by 288
TALEN and CRISPR/Cas Genome Editing Systems: Tools of Discovery
Nemudryi, A. A., Valetdinova, K. R., Medvedev, S. P., & Zakian, S. M. (2014) · Acta Naturae · doi:10.32607/20758251-2014-6-3-19-40 · Cited by 281
Selective gene dosage by CRISPR‐Cas9 genome editing in hexaploid Camelina sativa
Morineau, C., Bellec, Y., Tellier, F., Gissot, L., Kelemen, Z., Nogué, F., & Faure, J. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12671 · Cited by 281
Single-cell brain organoid screening identifies developmental defects in autism
Li, C., Fleck, J. S., Martins-Costa, C., Burkard, T. R., Themann, J., Stuempflen, M., Peer, A. M., Vertesy, Á., Littleboy, J. B., Esk, C., et al. (2023) · Nature · doi:10.1038/s41586-023-06473-y · Cited by 283
Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis
Zhang, Y., Heidrich, N., Ampattu, B. J., Gunderson, C. W., Seifert, H. S., Schoen, C., Vogel, J., & Sontheimer, E. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.001 · Cited by 284
Applications of CRISPR–Cas systems in neuroscience
Heidenreich, M., & Zhang, F. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.2 · Cited by 283
CHANGE-seq reveals genetic and epigenetic effects on CRISPR–Cas9 genome-wide activity
Lazzarotto, C. R., Malinin, N. L., Li, Y., Zhang, R., Yang, Y., Lee, G., Cowley, E., He, Y., Lan, X., Jividen, K., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0555-7 · Cited by 284
PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures
Gleditzsch, D., Pausch, P., Müller-Esparza, H., Özcan, A., Guo, X., Bange, G., & Randau, L. (2019) · RNA Biology · doi:10.1080/15476286.2018.1504546 · Cited by 280
“exist for one PAM and strand-specificity is frequently observed [6,32].”
BackgroundHighly efficient gene knockout in mice and zebrafish with RNA-guided endonucleases
Sung, Y. H., Kim, J. M., Kim, H.-T., Lee, J., Jeon, J., Jin, Y., Choi, J.-H., Ban, Y. H., Ha, S.-J., Kim, C.-H., et al. (2014) · Genome Research · doi:10.1101/gr.163394.113 · Cited by 283
“A single-guide RNA (sgRNA) generated by fusing crRNA and tracrRNA is also functional and can reprogram Cas9 protein to cleave a specific DNA sequence (Fig. 1A; Jinek et al. 2012).”
BackgroundA heterochromatin-dependent transcription machinery drives piRNA expression
Andersen, P. R., Tirian, L., Vunjak, M., & Brennecke, J. (2017) · Nature · doi:10.1038/nature23482 · Cited by 280
Friedland, A. E., Baral, R., Singhal, P., Loveluck, K., Shen, S., Sanchez, M., Marco, E., Gotta, G. M., Maeder, M. L., Kennedy, E. M., et al. (2015) · Genome Biology · doi:10.1186/s13059-015-0817-8 · Cited by 278
“Background The initial characterizations of CRISPR-Cas systems as mechanisms of bacterial and archaeal adaptive immunity [1–3] led to demonstrations of guide RNA (gRNA)-targeted DNA cleavage in vitro by the type II CRISPR-Cas nuclease Cas9 [4], and further experiments revealed the usefulness of these systems for genom…”
MethodAn alternative strategy for targeted gene replacement in plants using a dual-sgRNA/Cas9 design
Zhao, Y., Zhang, C., Liu, W., Gao, W., Liu, C., Song, G., Li, W.-X., Mao, L., Chen, B., Xu, Y., et al. (2016) · Scientific Reports · doi:10.1038/srep23890 · Cited by 275
Plant genome editing with TALEN and CRISPR
Malzahn, A., Lowder, L., & Qi, Y. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0148-4 · Cited by 274
“Currently, gene targets are somewhat limited by the NGG PAM site required by SpCas9 [38] (Table 1).”
BackgroundInfluentialGenome modification by CRISPR/Cas9
Ma, Y., Zhang, L., & Huang, X. (2014) · The FEBS Journal · doi:10.1111/febs.13110 · Cited by 266
Rational design of a split-Cas9 enzyme complex
Wright, A. V., Sternberg, S. H., Taylor, D. W., Staahl, B. T., Bardales, J. A., Kornfeld, J. E., & Doudna, J. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501698112 · Cited by 286
“The ability to program Cas9 for DNA cleavage at sites defined by engineered single-guide RNAs (sgRNAs) (4) has led to its adoption as a robust and versatile platform for genome engineering (for recent reviews, see refs.”
BackgroundMethodInfluentialSelf-citationCRISPR-Cpf1 mediates efficient homology-directed repair and temperature-controlled genome editing
Moreno-Mateos, M. A., Fernandez, J. P., Rouet, R., Vejnar, C. E., Lane, M. A., Mis, E., Khokha, M. K., Doudna, J. A., & Giraldez, A. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01836-2 · Cited by 287
Self-citationThe CRISPRs, They Are A-Changin': How Prokaryotes Generate Adaptive Immunity
Westra, E. R., Swarts, D. C., Staals, R. H. J., Jore, M. M., Brouns, S. J. J., & van der Oost, J. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155447 · Cited by 280
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 282
Self-citationEfficient CRISPR/Cas9-based gene knockout in watermelon
Tian, S., Jiang, L., Gao, Q., Zhang, J., Zong, M., Zhang, H., Ren, Y., Guo, S., Gong, G., Liu, F., et al. (2017) · Plant Cell Reports · doi:10.1007/s00299-016-2089-5 · Cited by 275
“throughout the genome and creates blunt-ended doublestrand break at about 3 bp upstream of the PAM site (Jinek et al. 2012).”
BackgroundInfluentialRapid breeding of parthenocarpic tomato plants using CRISPR/Cas9
Ueta, R., Abe, C., Watanabe, T., Sugano, S. S., Ishihara, R., Ezura, H., Osakabe, Y., & Osakabe, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-00501-4 · Cited by 256
Hartung, F., & Schiemann, J. (2014) · The Plant Journal · doi:10.1111/tpj.12413 · Cited by 277
“Over the last 2 years, details of the CRISPR/Cas9 nuclease (clustered regularly interspaced short palindromic repeats), a new kind of SDN, have emerged (Jinek et al., 2012; Wei et al., 2013).”
BackgroundGreiner, A., Kelterborn, S., Evers, H., Kreimer, G., Sizova, I., & Hegemann, P. (2017) · The Plant Cell · doi:10.1105/tpc.17.00659 · Cited by 276
“By far the most popular and widely used programmable nuclease system for gene modification in many organisms is clustered regularly interspaced short palindromic repeat (CRISPR)/ associated protein 9 (Cas9) technology (Jinek et al., 2012, 2013; Mali et al., 2013; Cong et al., 2013).”
MethodA CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9
Cui, L., Vigouroux, A., Rousset, F., Varet, H., Khanna, V., & Bikard, D. (2018) · Nature Communications · doi:10.1038/s41467-018-04209-5 · Cited by 286
Viral Delivery Systems for CRISPR
Xu, C. L., Ruan, M. Z. C., Mahajan, V. B., & Tsang, S. H. (2019) · Viruses · doi:10.3390/v11010028 · Cited by 277
“Furthermore, SpCas9 has been known to successfully carry out multiplex genome editing (CRISPR editing at multiple target sites) in mammalian cells through the aid of multiple single guide RNAs (sgRNAs) [67].”
BackgroundPinder, J., Salsman, J., & Dellaire, G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv993 · Cited by 279
OsMATL mutation induces haploid seed formation in indica rice
Yao, L., Zhang, Y., Liu, C., Liu, Y., Wang, Y., Liang, D., Liu, J., Sahoo, G., & Kelliher, T. (2018) · Nature Plants · doi:10.1038/s41477-018-0193-y · Cited by 275
Structural Basis for the RNA-Guided Ribonuclease Activity of CRISPR-Cas13d
Zhang, C., Konermann, S., Brideau, N. J., Lotfy, P., Wu, X., Novick, S. J., Strutzenberg, T., Griffin, P. R., Hsu, P. D., & Lyumkis, D. (2018) · Cell · doi:10.1016/j.cell.2018.09.001 · Cited by 276
Dugar, G., Herbig, A., Förstner, K. U., Heidrich, N., Reinhardt, R., Nieselt, K., & Sharma, C. M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003495 · Cited by 279
Reprogrammable CRISPR/Cas9-based system for inducing site-specific DNA methylation
McDonald, J. I., Celik, H., Rois, L. E., Fishberger, G., Fowler, T., Rees, R., Kramer, A., Martens, A., Edwards, J. R., & Challen, G. A. (2016) · Biology Open · doi:10.1242/bio.019067 · Cited by 275
“A Cas9 mutant (D10A and H840A; henceforth referred to as dCas9) that lacks endonuclease activity but can still be recruited by sgRNA(s) (Jinek et al., 2012) has recently been used to target genes in mammalian cells for transcriptional activation (Perez-Pinera et al.”
BackgroundInfluentialKim, D. Y., Lee, J. M., Moon, S. B., Chin, H. J., Park, S., Lim, Y., Kim, D., Koo, T., Ko, J.-H., & Kim, Y.-S. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01009-z · Cited by 274
Cady, K. C., Bondy-Denomy, J., Heussler, G. E., Davidson, A. R., & O'Toole, G. A. (2012) · Journal of Bacteriology · doi:10.1128/jb.01184-12 · Cited by 287
“These mature crRNAs are then complexed with subtype-specific Cas proteins, and this complex specifically interacts with nucleotide target sequences complementary to spacer sequences (5, 14, 16, 26).”
BackgroundCASFISH: CRISPR/Cas9-mediated in situ labeling of genomic loci in fixed cells
Deng, W., Shi, X., Tjian, R., Lionnet, T., & Singer, R. H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1515692112 · Cited by 277
“Nat Methods 10(11):1116–1121.”
MethodInfluentialEndoplasmic reticulum stress and eIF2α phosphorylation: The Achilles heel of pancreatic β cells
Cnop, M., Toivonen, S., Igoillo-Esteve, M., & Salpea, P. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.06.001 · Cited by 268
The future of CRISPR technologies in agriculture
Gao, C. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2018.2 · Cited by 271
PAM-Dependent Target DNA Recognition and Cleavage by C2c1 CRISPR-Cas Endonuclease
Yang, H., Gao, P., Rajashankar, K. R., & Patel, D. J. (2016) · Cell · doi:10.1016/j.cell.2016.11.053 · Cited by 277
CRISPR/cas systems redefine nucleic acid detection: Principles and methods
Wang, M., Zhang, R., & Li, J. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112430 · Cited by 268
Improvement of Salinity Stress Tolerance in Rice: Challenges and Opportunities
Hoang, T., Tran, T., Nguyen, T., Williams, B., Wurm, P., Bellairs, S., & Mundree, S. (2016) · Agronomy · doi:10.3390/agronomy6040054 · Cited by 269
Near-infrared upconversion–activated CRISPR-Cas9 system: A remote-controlled gene editing platform
Pan, Y., Yang, J., Luan, X., Liu, X., Li, X., Yang, J., Huang, T., Sun, L., Wang, Y., Lin, Y., et al. (2019) · Science Advances · doi:10.1126/sciadv.aav7199 · Cited by 271
Precision genome editing in plants: state-of-the-art in CRISPR/Cas9-based genome engineering
Wada, N., Ueta, R., Osakabe, Y., & Osakabe, K. (2020) · BMC Plant Biology · doi:10.1186/s12870-020-02385-5 · Cited by 266
Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A. O., Dickman, M. J., Horvath, P., & Siksnys, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.027 · Cited by 275
“It binds a dual RNA into the RNP effector complex, which then specifically cuts the matching target DNA, introducing a double-strand break (Gasiunas et al., 2012; Jinek et al., 2012).”
BackgroundCRISPR/Cas9-Mediated Genome Editing in Soybean Hairy Roots
Cai, Y., Chen, L., Liu, X., Sun, S., Wu, C., Jiang, B., Han, T., & Hou, W. (2015) · PLOS ONE · doi:10.1371/journal.pone.0136064 · Cited by 273
“The endonuclease Cas9 can be guided by a synthetic single-guide RNA to recognize target sequences and produce double strand breaks (DSBs) at desired target sites [13, 14].”
BackgroundJessop‐Fabre, M. M., Jakočiūnas, T., Stovicek, V., Dai, Z., Jensen, M. K., Keasling, J. D., & Borodina, I. (2016) · Biotechnology Journal · doi:10.1002/biot.201600147 · Cited by 278
“NGG for Streptococcus pyogenes-derived Cas9); Cas9 makes a blunt cut three nucleotides upstream of the PAM site [14].”
Programmable RNA detection with CRISPR-Cas12a
Rananaware, S. R., Vesco, E. K., Shoemaker, G. M., Anekar, S. S., Sandoval, L. S. W., Meister, K. S., Macaluso, N. C., Nguyen, L. T., & Jain, P. K. (2023) · Nature Communications · doi:10.1038/s41467-023-41006-1 · Cited by 266
“In contrast to Cas9, which uses two different active sites to generate a blunt double-stranded DNA break 47 , Cas12a uses a single active site to make staggered cuts on the two strands of a dsDNA 6,12,16 .”
Kumar, R., Das, S. P., Choudhury, B. U., Kumar, A., Prakash, N. R., Verma, R., Chakraborti, M., Devi, A. G., Bhattacharjee, B., Das, R., et al. (2024) · Biological Research · doi:10.1186/s40659-024-00562-6 · Cited by 228
Oligonucleotide Therapies: The Past and the Present
Lundin, K. E., Gissberg, O., & Smith, C. I. E. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.070 · Cited by 267
“A recent major development in molecular biology is the CRISPR-Cas technology for genome editing, first published in 2012.(60) This enzyme–RNA complex is dependent on two short RNA sequences, which may also be engineered as a single RNA chimera, ‘‘dual-tracrRNA:crRNA,’’ or guide RNA, serving as a very efficient tool fo…”
Optical Control of CRISPR/Cas9 Gene Editing
Hemphill, J., Borchardt, E. K., Brown, K., Asokan, A., & Deiters, A. (2015) · Journal of the American Chemical Society · doi:10.1021/ja512664v · Cited by 269
Repurposing CRISPR-Cas12b for mammalian genome engineering
Teng, F., Cui, T., Feng, G., Guo, L., Xu, K., Gao, Q., Li, T., Li, J., Zhou, Q., & Li, W. (2018) · Cell Discovery · doi:10.1038/s41421-018-0069-3 · Cited by 261
Hu, M., Yuan, C., Tian, T., Wang, X., Sun, J., Xiong, E., & Zhou, X. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c00217 · Cited by 267
Jiang, W., Zhao, X., Gabrieli, T., Lou, C., Ebenstein, Y., & Zhu, T. F. (2015) · Nature Communications · doi:10.1038/ncomms9101 · Cited by 267
Degenerate target sites mediate rapid primed CRISPR adaptation
Fineran, P. C., Gerritzen, M. J. H., Suárez-Diez, M., Künne, T., Boekhorst, J., van Hijum, S. A. F. T., Staals, R. H. J., & Brouns, S. J. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400071111 · Cited by 275
Becker, J., Rohles, C. M., & Wittmann, C. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.07.008 · Cited by 270
Cas9 versus Cas12a/Cpf1: Structure–function comparisons and implications for genome editing
Swarts, D. C., & Jinek, M. (2018) · WIREs RNA · doi:10.1002/wrna.1481 · Cited by 267
Efficient and Heritable Gene Targeting in Tilapia by CRISPR/Cas9
Li, M., Yang, H., Zhao, J., Fang, L., Shi, H., Li, M., Sun, Y., Zhang, X., Jiang, D., Zhou, L., et al. (2014) · Genetics · doi:10.1534/genetics.114.163667 · Cited by 268
“Importantly, previous studies performed in vitro (Jinek et al. 2012), in bacteria (Jiang et al. 2013), and in human cells (Cong et al. 2013) have shown that Cas9-mediated cleavage can be abolished by single mismatch at the gRNA–target site interface, particularly in the last 10–12 nucleotides…”
BackgroundPaix, A., Wang, Y., Smith, H. E., Lee, C.-Y. S., Calidas, D., Lu, T., Smith, J., Schmidt, H., Krause, M. W., & Seydoux, G. (2014) · Genetics · doi:10.1534/genetics.114.170423 · Cited by 282
“We designed ssODNs and sgRNAs (Jinek et al. 2012) to target Cas9 to eight different loci in five genes using genomic sequence information available on WormBase (sgRNA and ssODN sequences used for each experiment are listed in Table S1, Table S2, and Table S3).”
BackgroundMethodEfficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9
Du, H., Zeng, X., Zhao, M., Cui, X., Wang, Q., Yang, H., Cheng, H., & Yu, D. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.11.005 · Cited by 263
Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease
Dahlman, J. E., Abudayyeh, O. O., Joung, J., Gootenberg, J. S., Zhang, F., & Konermann, S. (2015) · Nature Biotechnology · doi:10.1038/nbt.3390 · Cited by 272
Corynebacterium glutamicum Metabolic Engineering with CRISPR Interference (CRISPRi)
Cleto, S., Jensen, J. V., Wendisch, V. F., & Lu, T. K. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.5b00216 · Cited by 262
Consequences of Cas9 cleavage in the chromosome of Escherichia coli
Cui, L., & Bikard, D. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw223 · Cited by 276
“Alternatively, the crRNA and tracrRNA can be fused forming a chimeric single guide RNA (sgRNA) (5).”
BackgroundProgrammed genome editing by a miniature CRISPR-Cas12f nuclease
Wu, Z., Zhang, Y., Yu, H., Pan, D., Wang, Y., Wang, Y., Li, F., Liu, C., Nan, H., Chen, W., et al. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00868-6 · Cited by 272
Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
Gundry, M. C., Brunetti, L., Lin, A., Mayle, A. E., Kitano, A., Wagner, D., Hsu, J. I., Hoegenauer, K. A., Rooney, C. M., Goodell, M. A., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.092 · Cited by 265
“…site specific genome editing, the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9) system (Jinek et al., 2012) stands out since it does not require cumbersome engineering of nucleases for each target but only requires a 20 nucleotide RNA…”
BackgroundA compact, high-accuracy Cas9 with a dinucleotide PAM for in vivo genome editing
Edraki, A., Mir, A., Ibraheim, R., Gainetdinov, I., Yoon, Y., Song, C.-Q., Cao, Y., Gallant, J., Xue, W., Rivera-Pérez, J. A., et al. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.12.003 · Cited by 265
“The Nme2Cas9 all-in-one AAV delivery platform established in this study can in principle be used to target as wide a range of sites as SpyCas9 (due to the identical densities of N4CC and NGG PAMs), but without the need to deliver two separate vectors to the same target cells.”
BackgroundInfluentialHoshijima, K., Jurynec, M. J., Klatt Shaw, D., Jacobi, A. M., Behlke, M. A., & Grunwald, D. J. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.10.004 · Cited by 260
Highly efficient CRISPR mutagenesis by microhomology-mediated end joining in Aspergillus fumigatus
Zhang, C., Meng, X., Wei, X., & Lu, L. (2016) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2015.12.007 · Cited by 264
(Ph)ighting Phages: How Bacteria Resist Their Parasites
Rostøl, J. T., & Marraffini, L. (2019) · Cell Host & Microbe · doi:10.1016/j.chom.2019.01.009 · Cited by 270
“In addition to this complementarity, cleavage requires the presence of a conserved protospacer adjacent motif (PAM) in one flank of the target (Gasiunas et al., 2012; Jinek et al., 2012; Sashital et al., 2012; Zetsche et al., 2015).”
Improved split fluorescent proteins for endogenous protein labeling
Feng, S., Sekine, S., Pessino, V., Li, H., Leonetti, M. D., & Huang, B. (2017) · Nature Communications · doi:10.1038/s41467-017-00494-8 · Cited by 272
DEG 15, an update of the Database of Essential Genes that includes built-in analysis tools
Luo, H., Lin, Y., Liu, T., Lai, F.-L., Zhang, C.-T., Gao, F., & Zhang, R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa917 · Cited by 271
Loss of function of a DMR6 ortholog in tomato confers broad-spectrum disease resistance
Thomazella, D. P. D. T., Seong, K., Mackelprang, R., Dahlbeck, D., Geng, Y., Gill, U. S., Qi, T., Pham, J., Giuseppe, P., Lee, C. Y., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026152118 · Cited by 262
CRISPR technologies for genome, epigenome and transcriptome editing
Villiger, L., Joung, J., Koblan, L., Weissman, J., Abudayyeh, O. O., & Gootenberg, J. S. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00697-6 · Cited by 256
“Its simplicity and programmability 6 , especially when contrasted with older DNA editing tools, such as zinc-finger nucleases 7–11 or TALE nucleases 12–15 , make Cas9 exceptionally suited for mammalian genome engineering 16–20 .”
Synthetic nucleases for genome engineering in plants: prospects for a bright future
Puchta, H., & Fauser, F. (2014) · The Plant Journal · doi:10.1111/tpj.12338 · Cited by 261
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Vaidyanathan, S., Azizian, K. T., Haque, A. K. M. A., Henderson, J. M., Hendel, A., Shore, S., Antony, J. S., Hogrefe, R. I., Kormann, M. S. D., Porteus, M. H., et al. (2018) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2018.06.010 · Cited by 262
CRISPR/Cas9‐mediated genome engineering: An adeno‐associated viral (AAV) vector toolbox
Senís, E., Fatouros, C., Große, S., Wiedtke, E., Niopek, D., Mueller, A., Börner, K., & Grimm, D. (2014) · Biotechnology Journal · doi:10.1002/biot.201400046 · Cited by 260
Weninger, A., Hatzl, A.-M., Schmid, C., Vogl, T., & Glieder, A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.03.027 · Cited by 264
Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization
Roberts, B., Haupt, A., Tucker, A., Grancharova, T., Arakaki, J., Fuqua, M. A., Nelson, A., Hookway, C., Ludmann, S. A., Mueller, I. A., et al. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-03-0209 · Cited by 262
Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense
Westra, E. R., van Houte, S., Oyesiku-Blakemore, S., Makin, B., Broniewski, J. M., Best, A., Bondy-Denomy, J., Davidson, A., Boots, M., & Buckling, A. (2015) · Current Biology · doi:10.1016/j.cub.2015.01.065 · Cited by 271
CRISPR/Cas9-Mediated Targeted Mutagenesis in the Liverwort Marchantia polymorpha L.
Sugano, S. S., Shirakawa, M., Takagi, J., Matsuda, Y., Shimada, T., Hara-Nishimura, I., & Kohchi, T. (2014) · Plant and Cell Physiology · doi:10.1093/pcp/pcu014 · Cited by 269
Khan, A., Pan, X., Najeeb, U., Tan, D. K. Y., Fahad, S., Zahoor, R., & Luo, H. (2018) · Biological Research · doi:10.1186/s40659-018-0198-z · Cited by 261
IFT27 Links the BBSome to IFT for Maintenance of the Ciliary Signaling Compartment
Eguether, T., San Agustin, J. T., Keady, B. T., Jonassen, J. A., Liang, Y., Francis, R., Tobita, K., Johnson, C. A., Abdelhamed, Z. A., Lo, C. W., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.09.011 · Cited by 260
“CRIPSR/Cas9 genome editing Candidate sgRNAs were identified by searching for G(N)20GG motifs 300 bases upstream and 100 bases downstream of the targeting sequence that conform with the nucleotide requirements for U6 Pol III transcription and the spCas9 PAM recognition element (NGG) (Jinek et al., 2012; Mali et al., 20…”
MethodInfluentialThe roles of CRISPR–Cas systems in adaptive immunity and beyond
Barrangou, R. (2015) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.12.008 · Cited by 259
Metadata
- Authors
- Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E.
- Affiliations
- Howard Hughes Medical Institute (HHMI), University of California, Berkeley, CA 94720, USA.
- University of Vienna (AT)
- Umeå Centre for Microbial Research (SE)
- University of California, Berkeley (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Chylinski, Krzysztof
- Doudna, Jennifer A.
- Charpentier, Emmanuelle
- Venue
- Science
- Published
- 2012-08-17
- Volume
- 337
- Issue
- 6096
- Pages
- 816-821
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6286148
- OpenAlex
- W2045435533
- Semantic Scholar
- 68d962effe5520777791bd6ec8ffa4b963ba4f38
- Cited by
- 17,116
- References
- 48
- Citations by year
- 2026: 1083 · 2025: 1512 · 2024: 1602 · 2023: 1572 · 2022: 1795 · 2021: 1793 · 2020: 1577 · 2019: 1344 · 2018: 1255 · 2017: 1141 · 2016: 1018 · 2015: 680 · 2014: 467 · 2013: 231 · 2012: 29
- FWCI
- 180.75
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- CRISPR/Cas9, sequence-specific DNA cleavage, DNA double-strand breaks
- MeSH terms
- Bacteriophages, Base Sequence, Molecular Sequence Data, Nucleic Acid Conformation, Plasmids, RNA, Streptococcus pyogenes, Deoxyribonucleases, Type II Site-Specific, DNA Cleavage, DNA Breaks, Double-Stranded, Inverted Repeat Sequences
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.